News|Articles|November 21, 2024
Ensure the Safety of Allogeneic Therapies with Advanced qPCR Testing
Author(s)Eurofins
Elevate your viral screening with Eurofins BioPharma Product Testing’s qPCR- based assays. Our advanced testing goes beyond standard screenings to detect even dormant and hard-to-detect pathogens, ensuring comprehensive safety in every stage of the allogeneic therapy pipeline. Protect your products – and your patients- with industry-leading sensitivity and specificity.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Proteasomes: A Novel Approach to Target the Immune System
2
West Launches New Prefillable Syringe System that Streamlines Biologic Delivery
3
The Shift from Containment to Protection: Packaging Trends Impacting Pharma
4
State of the Bio/Pharma Workforce: A Comparative Analysis of Employment Trends and Industry Sentiment
5